These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 21540097)

  • 1. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
    Zhang P; Liu X; Hu W; Bai Y; Zhang L
    Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
    Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
    Deng F; Hu W; Chen H; Tang Y; Zhang L
    Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery.
    Khalil SK; El-Feky GS; El-Banna ST; Khalil WA
    Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
    Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
    J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
    Fan W; Yan W; Xu Z; Ni H
    Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studies.
    Bhatta RS; Chandasana H; Chhonker YS; Rathi C; Kumar D; Mitra K; Shukla PK
    Int J Pharm; 2012 Aug; 432(1-2):105-12. PubMed ID: 22569234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
    Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
    Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
    Wu J; Shen Q; Fang L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.